Organization | Hospital Xeral Cies de Vigo

Hospital Xeral Cies de Vigo Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Vigo Spain (1955)

Organization Overview

First Clinical Trial

2005

NCT00711308

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2013

Timeline

NOW

Now

Alternative names

Hospital clinico universitario Vigo | Hospital Xeral de Vigo | Hospital Xeral (Vigo)

Active Ingredients

Drugs in Phase 4 Trials (4)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

sintrom (1 trial)

tinzaparin (Innohep) (1 trial)

Drugs in Phase 2 Trials (5)

fluorouracil (efudex) (1 trial)

leucovorin (1 trial)

oxaliplatin (eloxatin) (1 trial)

panitumumab (vectibix) (1 trial)

trifolium pratense (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Aortic Valve Stenosis (Phase 4)

Colorectal Neoplasms (Phase 2)

Conjunctivitis (Phase 2)

Embolism (Phase 4)

Intracranial Embolism (Phase 4)

Pulmonary Embolism (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial APIs: 9